Research Article
Polymorphisms -455G/A and -148C/T and Fibrinogen Plasmatic Level as Risk Markers of Coronary Disease and Major Adverse Cardiovascular Events
Table 5
Adverse cardiovascular events to one year.
| UCD () polymorphism | Nonevent () | Adverse event () | Type of MACE (one year) | Angina () | Reinfarct () | Shock () | Death () |
| -455 | | | | | | | G/G | 9 | 19 | 16 | 3 | 4 | 4 | G/A+A/A | 8 | 14 | 14 | 2 | 1 | 3 | -148 | | | | | | | C/C | 10 | 8 | 6 | 0 | 2 | 3 | C/T+T/T | 7 | 25 | 24# | 5 | 3 | 4 | Bcl-1 | | | | | | | B1/B1 | 13 | 26 | 22 | 4 | 3 | 4 | B1/B2+B2/B2 | 4 | 7 | 8 | 1 | 2 | 3 | +1689 | | | | | | | T/T | 9 | 19 | 17 | 3 | 5 | 4 | G/T+G/G | 8 | 14 | 13 | 2 | 0 | 1 |
|
|
|